Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis

• References

• 1 Edwards RL, Morgan DL, Rickies FR. Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemostas 1990; 63: 133-138
• 2 Edwards RL, Rickies FR. Leukocytes and tumor cells in thrombosis. In: Hemostasis and Thrombosis. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) JB Lippincott; Philadelphia, PA: in press
• 3 Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72: 128-133
• 4 Cozzolino F, Torcia M, Miliani A, Carossino AM, Giordani R, Cinotti S, Filimberti E, Saccardi R, Bernabei P, Guidi G, DiGug-lielmo R, Pistoia V, Ferrarini M, Nawroth PP, Stern D. Potential role of Interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 1988; 84: 240-250
• 5 Dover R, Goeting NLM, Taylor I, Roath OS, Francis JL. Factor X-activating activity in patients with colorectal carcinoma. Br J Surg 1987; 74: 1122-1124
• 6 Bastida E, Ordinas A, Escolar G, Jamieson GA. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 1984; 64: 177-184
• 7 Rana SV, Reimers HJ, Pathikonda MS, Bajaj SP. Expression of tissue factor and factor VII/tissue factor inhibitor activity in endotoxin or phorbal ester stimulated U937 monocyte-like cells. Blood 1988; 71: 259-262
• 8 Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988; 71: 870-875
• 9 Donati MB, Gambacorti-Passerini C, Casali B, Falanga A, Vannotti P, Fossati G, Semeraro N, Gordon SG. Cancer procoagulant in human tumor cells: Evidence frr melanoma patients. Cancer Res 1986; 46: 6471-6474
• 10 Cajot JF, Kruithof EKO, Schleuning WD, Sordat B, Bachmann F. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 1986; 38: 719-727
• 11 Mussoni L, Conforti G, Gambacorti-Passerini C, Alessio G, Pepe M, Vaghi M, Erba E, Amato G, Landoni F, Mangione C, Morasca L, Semeraro N, Donati MB. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. Eur J Clin Oncol 1986; 22: 373-380
• 12 Kitagawa H, Yamamoto N, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells. Cancer Res 1989; 49: 537-541
• 13 Esumi N, Todo S, Imashuku S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987; 47: 2129-2135
• 14 Grignani G, Falanga A, Pachiarini L, Alessio MG, Zucchella M, Fratino P, Donati MB. Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties. Int J Cancer 1988; 42: 554-557
• 15 Wijermans PW, Rebel VI, Ossenkoppele GJ, Huijgens PC, Langenhuijsen MMAC. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemia cells: reversal of the bleeding disorder by cell differentiation. Blood 1989; 73: 800-805
• 16 Curatolo L, Alessio G, Gambacorti-Passerini C, Casali B, Morasca L, Semeraro N, Donati MB. Procoagulant activity of mouse and human cultured cells following various types of transformation. Int J Cancer 1985; 35: 411-414
• 17 Guarini A, Gugliotta L, Timoncini C, Chetti L, Catani L, Russo D, Tura S. Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukemia. Scand J Haematol 1985; 34: 152-156
• 18 Chorba TL, Orenstein JM, Ney AB, Schwartz BS, Alabaster O, Kessler CM, Cohen P, Schulof RS. Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity. Cancer 1985; 55: 675-681
• 19 Gralnick HR, Abrell E. Studies of the Procoagulant and the fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol 1973; 24: 89-99
• 20 Rickies FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 1983; 62: 14-31
• 21 Dvorak HF, Van DeWater L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho ACA. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43: 4334-4342
• 22 Hudig D, Bajaj SP. Tissue factor-like activity of the human monocytic tumor cell line U937. Thromb Res 1982; 27: 321-322
• 23 Sakuragawa N, Takahashi K, Hoshiyama M, Jimbo C, Ashizawa K, Matsuoka M, Ohnishi Y. The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res 1977; 10: 457-463
• 24 Ewan VA, Edwards RL, Rickies FR. Expression of procoagulant activity in a human monocyte like cell line. J Lab Clin Med 1983; 101: 401-410
• 25 Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. Thromb Res 1975; 6: 127-137
• 26 Gordon SG, Gilbert LC, Lewis BJ. Analysis of PC A of intact cells from tissue culture. Thromb Res 1982; 26: 379-387
• 27 Pineo AF, Brain MC, Gallus AS, Hirsh J, Hatton MWC, Regoeczi E. Tumors, mucus production and hypercoagulability. Ann NY Acad Sci 1974; 230: 262-270
• 28 Sakuagawa N, Takahashi K, Hoshiyama M, Jimbo C, Matsuoka M, Onishi Y. Pathologic cells as procoagulant substance of disseminated intravascular coagulation in acute promyelocytic leukemia. Thromb Res 1976; 8: 263-273
• 29 Kinjo M, Oka K, Naito S, Kohga S, Tanaka K, Oboshi S, Hayaka Y, Yasumoto K. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer 1979; 39: 15-23
• 30 O’Meara RAQ, Thornes RD. Some properties of the cancer coagulative factor. Irish J Med Sci 1961; 423: 106-112
• 31 Boggust WA, O’Brien DJ, O’Meara RAQ, Thornes RD. The coagulative factors of normal human and human cancer tissue. Irish J Med Sci 1963; 447: 131-144
• 32 Svanberg L. Thromboplastic activity of human ovarian tumours. Thromb Res 1975; 6: 307-313
• 33 Gordon SG, Franks JJ, Lewis BJ. Comparison of procoagulant activity in extracts of normal and malignant human tissue. J Natl Cancer Inst 1979; 62: 773-778
• 34 Karhumaki E, Saravo L, Helin H. Cells of the human myelomonocytic cell line RC2A synthesize tissue factor-like procoagulant and urokinase type plasminogen activator. J Leuk Biol 1987; 42: 36-42
• 35 Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262: 11692-11698
• 36 Geczy CL, Jones A. Procoagulant induction by human lymphokine and interferon ϒ/PMA on a myelomonocytic cell line, RC2a. Br J Haematol 1988; 70: 211-218
• 37 Kornberg A, Treves A, Rachmilewitz EA, Fibach E. Generation of procoagulant activity (PCA) by phorbol-esters-induced macrophage derived from a leukemic promyelocytic cell line (HL60). Blood 1982; 59: 1061-1066
• 38 Grignani G, Jamieson GA. TF-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. Invasion Metastasis 1987; 7: 172-182
• 39 Gambarcorti-Passerini C, Semeraro N, Pourli MD, Gordon SG. Cancer procoagulant and haemostatic abnormalities in melanoma. Lancet 1986; 1: 920
• 40 Gouault-Heilmann M, Chadon E, Sultan C, Josso F. The procoagulant factor of leukemic promyelocytes. Demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1975; 30: 151-158
• 41 Tanaka M. Induction of tissue factor like activity of human monoblastic leukemia cell line by tumor necrosis factor-alpha. Thromb Res 1989; 56: 201-211
• 42 Barrowcliffe TW, Marshall DE, Trickett LP, Hubbard AR, Gray E, Thorpe R. Procoagulant activity of T-lymphoblastoid cells in extrinsic and intrinsic coagulation systems. Thromb Haemostas 1989; 62: 880-894
• 43 Silberberg JM, Gordon S, Zucker S. Identification of tissue factor into pancreatic cancer cell lines. Cancer Res 1989; 49: 5443-5447
• 44 Viero P, Cortelazzo S, Barbui T, Semeraro N. Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters. Eur J Clin Cancer Oncol 1986; 22: 857-862
• 45 Sakai T, Lund-Hansen T, Parborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem 1989; 17: 9980-9988
• 46 Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N. Tissue factor released from leukemic cells. Thromb Haemostas 1991; 65: 59-63
• 47 Donati MB, Falanga A, Consonni R, Alessio MG, Bassan R, Buelli M, Borin L, Catani L, Pogliani E, Gugliotta L. et al. Cancer procoagulant in acute non-lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haemostas 1990; 64: 11-16
• 48 Alessio MG, Falanga A, Consonni R, Bassan R, Minetti B, Donati MB, Barbui T. Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990; 45: 78-81
• 49 Bauer KA, Conway EM, Bach R, Konigsberg WH, Griffin JD, Demetri G. Tissue gene expression in acute myeloblastic leukemia. Thromb Res 1989; 56: 425-430
• 50 Sakai T, Kisiel W. Binding of human factors X and Xa to HepG2 and J82 human tumor cells. J Biol Chem 1990; 265: 9105-9113
• 51 Parmar J, Taylor I, Roath S, Francis J. Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coag Fibrinolys 1990; 1: 127-132
• 52 el-Baruni K, Taylor I, Roath S, Francis JL. Factor X-activating procoagulant in normal and malignant breast tissue. Hematol Oncol 1990; 8: 323-332
• 53 Pacchiarini L, Meloni F, Zucchella M, Mangiarotti P, Tacconi F, Ballabio P, Grignani G. Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of “in vitro” culture. Haematologica 1991; 76: 392-397
• 54 Celladurai M, Honn KV, Walz Da. HLA-DR is procoagulant. Biochem Biophys Res Commun 1991; 178: 467-473